Ekso Bionics Holdings, Inc. - Common Stock (EKSO)

The military landscape has always been a dynamic arena, shaped by technological advancements, geopolitical shifts, and evolving threats. As we stand in 2025, the world is on the cusp of transformative changes that will redefine how nations defend their interests, project power, and maintain peace—or wage war. From artificial

Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial.

Ekso Bionics stock is down on Tuesday as investors in the company react to its lackluster earnings report for the second quarter of the year.

Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!

EKSO stock results show that Ekso Bionics Holdings met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

The best Robotic Exoskeletons stocks are highly lucrative, given recent industry developments and growing product uptake.

EKSO stock results show that Ekso Bionics Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results.

It's time to start off trading this morning with a breakdown of the biggest pre-market stock movers worth watching on Tuesday!

EKSO stock results show that Ekso Bionics Holdings missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.